dehydroxymethylepoxyquinomicin,
DHMEQ cpd,
DHMEQ,
287194-40-5,
Dehydroxymethylepoxyquinomicin,
(-)-DHMEQ,
2-Hydroxy-N-((1S,2S,6S)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)benzamide,
(-)-DHM2EQ,
2-hydroxy-N-[(1S,2S,6S)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzamide,
287194-38-1,
CHEMBL169300,
SCHEMBL1671089,
CTK8C1942,
DTXSID00432307,
IUOMATKBBPCLFR-TUAOUCFPSA-N,
(-)-Dehydroxymethylepoxyquinomicin,
ANW-67481,
ZINC27991010,
AKOS015924390,
CS-5488,
AJ-83380,
HY-14645,
AX8237305,
TC-156226,
Benzamide, 2-hydroxy-N-[(1S,2S,6S)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-,
DHMEQ cpd,
DHM2EQ,
DHM3EQ,
D0Y9GA,
NFkappaB inhibitors, Keio/Mercian,
CID9881652,
Epoxyquinomicin derivatives, Keio/Mercian,
A16302,
C464444,
2-hydroxy-N-(2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)benzamide,
Cis(+/-)-2-hydroxy-N-(2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)benzamide,
Trans-2-hydroxy-N-(2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)benzamide,